Early-onset cancers (<50 yrs) are rising globally, linked to early-life exposures like diet, lifestyle, & microbiome changes. Awareness & dedicated studies are crucial. #Cancer #EarlyOnsetCancer #Oncology @oncoalert.bsky.social rdcu.be/d49Ol

#Subcutaneous nivolumab approved by @fda.gov across all indications - follows approval of SC atezolizumab in Sept 2024. Will this be the preferred route of administration or will this suppress the development of new biosimilars? @oncodaily.bsky.social @hemoncwarner.bsky.social

Scientists, academics, researchers: We’re excited to share that @altmetric.com is now tracking mentions of your research on Bluesky! 🧪

Wow #bluesky added to #altrimetric scores!

Hugely interesting paper in #nature about #SONIA trial challenging frontline CDK4/6 use in #breastcancer - does this have implications for practice today? www.nature.com/articles/s41...

How to Keep Up With Molecular Testing and Targeted Therapies in Lung Cancer | JCO Oncology Practice ascopubs.org/doi/10.1200/... #LCSM

The World Health Organization notes 300 essential drugs are now in shortage. What's behind the problems and what are countries doing about it? www.bmj.com/content/387/...